Literature DB >> 25188594

Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.

Atin Saha1, Kyung K Peck, Eric Lis, Andrei I Holodny, Yoshiya Yamada, Sasan Karimi.   

Abstract

STUDY
DESIGN: A total of 40 patients with spinal metastases from renal cell carcinomas (RCCs) or prostate carcinomas (PCs) were studied using DCE-MRI (dynamic contrast-enhanced magnetic resonance imaging).
OBJECTIVE: To evaluate spinal metastases from RCC and PC to assess the sensitivity and specificity of perfusion parameters obtained by quantitative and semiquantitative methods, which would allow for noninvasive discrimination between hypovascular and hypervascular lesions. SUMMARY OF BACKGROUND DATA: Conventional MRI can be inconclusive in assessing diagnostically complex spinal lesions in patients with cancer in whom fibrosis, infarction, edema related to compression fractures, and infection may simulate malignant neoplasm. Conventional MRI is also of limited value in assessing tumor vascularity and identifying hypervascular tumors. DCE-MRI offers an advantage over conventional MRI in that it provides anatomical, physiological, and hemodynamic information about neoplastic lesions.
METHODS: DCE perfusion parameters: vascular permeability, plasma volume (V(p)), wash-in slope, and peak-enhancement parameter were measured to assess their potential as discriminators of tumor vascularity. A Mann-Whitney U test (at P ≤ 0.01), was performed to quantify and compare significance of perfusion parameters between the 2 groups.
RESULTS: Of the 4 perfusion parameters studied, V(p) was observed to have the largest difference in mean (μ) between PC (μ = 3.29/s) and RCC metastases (μ = 5.92/s). This was followed by the peak-enhancement, vascular permeability, and wash-in parameters. A Mann-Whitney U test showed a significant difference between V(p) values for PC and RCC lesions (P ≤ 0.001). Similarly, peak-enhancement parameter showed a significant difference between the 2 histologies (P ≤ 0.001), as did vascular permeability (P ≤ 0.01). The receiver operating characteristic curve showed that V(p) recorded the highest area under the curve (0.867).
CONCLUSION: V(p) was shown to be the best discriminator between spinal metastases from PC and RCC with the mean V(p) of RCC metastasis being 1.8 times that of the PC lesions, thus discriminating between hyper- and hypovascular metastases, which has important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25188594      PMCID: PMC4465934          DOI: 10.1097/BRS.0000000000000570

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  28 in total

1.  Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast.

Authors:  P J Drew; M J Kerin; T Mahapatra; C Malone; J R Monson; L W Turnbull; J N Fox
Journal:  Eur J Surg Oncol       Date:  2001-11       Impact factor: 4.424

2.  Detection of malignant bone marrow involvement with dynamic contrast-enhanced magnetic resonance imaging.

Authors:  L A Moulopoulos; T G Maris; N Papanikolaou; G Panagi; L Vlahos; M A Dimopoulos
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

3.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging.

Authors:  Xiaohong Joe Zhou; Norman E Leeds; Graeme C McKinnon; Ashok J Kumar
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

5.  Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging.

Authors:  R Erlemann; M F Reiser; P E Peters; P Vasallo; B Nommensen; C R Kusnierz-Glaz; J Ritter; A Roessner
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

6.  Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging.

Authors:  N R Khadem; S Karimi; K K Peck; Y Yamada; E Lis; J Lyo; M Bilsky; H A Vargas; A I Holodny
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

7.  Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging.

Authors:  Jean-Luc Montazel; Marine Divine; Eric Lepage; Hicham Kobeiter; Stephane Breil; Alain Rahmouni
Journal:  Radiology       Date:  2003-10-30       Impact factor: 11.105

8.  Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer.

Authors:  P J Kneeshaw; L W Turnbull; A Smith; P J Drew
Journal:  Eur J Surg Oncol       Date:  2003-02       Impact factor: 4.424

9.  A profile of metastatic carcinoma of the spine.

Authors:  J Schaberg; B J Gainor
Journal:  Spine (Phila Pa 1976)       Date:  1985 Jan-Feb       Impact factor: 3.468

10.  Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy.

Authors:  Stacy Chu; Sasan Karimi; Kyung K Peck; Yoshiya Yamada; Eric Lis; John Lyo; Mark Bilsky; Andrei I Holodny
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-15       Impact factor: 3.468

View more
  14 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.

Authors:  Eric Lis; Atin Saha; Kyung K Peck; Joan Zatcky; Michael J Zelefsky; Yoshiya Yamada; Andrei I Holodny; Mark H Bilsky; Sasan Karimi
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

2.  Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced MRI.

Authors:  K A Morales; J Arevalo-Perez; K K Peck; A I Holodny; E Lis; S Karimi
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-12       Impact factor: 3.825

3.  Assessing Vascularity of Osseous Spinal Metastases with Dual-Energy CT-DSA: A Pilot Study Compared with Catheter Angiography.

Authors:  Y-C Huang; F-Y Tsuang; C-W Lee; C-Y Wu; Y-H Lin
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-04       Impact factor: 3.825

4.  T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.

Authors:  P Santos; K K Peck; J Arevalo-Perez; S Karimi; E Lis; Y Yamada; A I Holodny; J Lyo
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

5.  Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.

Authors:  Ning Lang; Yang Zhang; Enlong Zhang; Jiahui Zhang; Daniel Chow; Peter Chang; Hon J Yu; Huishu Yuan; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2019-02-28       Impact factor: 2.546

6.  Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.

Authors:  Ning Lang; Huishu Yuan; Hon J Yu; Min-Ying Su
Journal:  Acad Radiol       Date:  2017-02-02       Impact factor: 3.173

7.  Dynamic contrast-enhanced MRI for the assessment of spinal tumor vascularity: correlation with angiography.

Authors:  Xiao-Xi Meng; Yong-Qiu Zhang; Hua-Qiang Liao; Hong-Chao Liu; Hai-Lin Jiang; Shu-Jun Ke; Wei-Hua Dong
Journal:  Eur Spine J       Date:  2016-07-23       Impact factor: 3.134

8.  T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.

Authors:  Youxin Guan; Kyung K Peck; John Lyo; Jamie Tisnado; Eric Lis; Julio Arevalo-Perez; Yoshiya Yamada; Meera R Hameed; Sasan Karimi; Andrei Holodny
Journal:  Radiology       Date:  2020-09-01       Impact factor: 11.105

9.  Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT.

Authors:  Jiahui Zhang; Yongye Chen; Yanyan Zhang; Enlong Zhang; Hon J Yu; Huishu Yuan; Yang Zhang; Min-Ying Su; Ning Lang
Journal:  Eur Spine J       Date:  2019-11-21       Impact factor: 3.134

Review 10.  An Overview of Decision Making in the Management of Metastatic Spinal Tumors.

Authors:  Gautam R Zaveri; Reetu Jain; Nishank Mehta; Bhavuk Garg
Journal:  Indian J Orthop       Date:  2021-03-06       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.